Omega-3 Plus Low-Dose Aspirin in Smokers With Stage III Periodontitis

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Periodontal Disease, Periodontitis (Stage 3), Smoking Behaviors

In brief

This randomized double-blind placebo-controlled clinical trial aims to evaluate the clinical and biochemical effects of omega-3 fatty acids combined with low-dose aspirin as an adjunct to scaling and root planing (SRP) in smoker patients with Stage III periodontitis. The study compares test and control groups regarding periodontal clinical parameters and gingival crevicular fluid interleukin-1 beta (IL-1β) levels Or other inflammatory markers that will be determined later at baseline, 3 months, and 6 months following treatment

Key facts

Study ID
NCT07673185
Run by
Al-Azhar University
People needed
40
Starts
2025-01-15
Expected to finish
2026-10-30
Last updated by the study team
2026-07-08

Who can join

Age: 30 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.